Synthesis 2019; 51(02): 573-577
DOI: 10.1055/s-0037-1610291
paper
© Georg Thieme Verlag Stuttgart · New York

Synthesis and Antitumor Activity of Novel 1-Substituted 3-(4,5-Substituted 1,2,4-Triazol-3-yl)-β-carboline Derivatives

George Brand
a   Departamento de Química, Universidade Estadual de Maringá, Av. Colombo 5790, Maringá - PR, 87020-900, Brazil   Email: mhsarragiotto@uem.br
,
Carla M. B. Gomes
a   Departamento de Química, Universidade Estadual de Maringá, Av. Colombo 5790, Maringá - PR, 87020-900, Brazil   Email: mhsarragiotto@uem.br
,
Willian F. Costa
a   Departamento de Química, Universidade Estadual de Maringá, Av. Colombo 5790, Maringá - PR, 87020-900, Brazil   Email: mhsarragiotto@uem.br
,
Mary A. Foglio
b   Faculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas, Campinas - SP, 13083-859, Brazil
,
Ana L. T. G. Ruiz
c   Centro Pluridisciplinar de Pesquisas Químicas, Biológicas e Agrícolas (CPQBA), Universidade Estadual de Campinas, Campinas - SP, 13083-970, Brazil
,
Maria H. Sarragiotto*
a   Departamento de Química, Universidade Estadual de Maringá, Av. Colombo 5790, Maringá - PR, 87020-900, Brazil   Email: mhsarragiotto@uem.br
› Author Affiliations
This work was supported by Fundação Araucária (Brazil, PR) and Fundação de Amparo à Pesquisa de São Paulo (FAPESP).
Further Information

Publication History

Received: 04 July 2018

Accepted after revision: 30 August 2018

Publication Date:
26 September 2018 (online)


Abstract

Schiff bases, 1,2,4-triazolo[4,3-d][1,2,3,4]thiatriazoles, and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles carrying the β-carboline nucleus were synthesized from 3-(4-amino-5-mercapto-1,2,4-triazol-3-yl)-β-carbolines. The compounds were evaluated for their in vitro antitumor activity against eight human cancer cell lines. The 1,2,4-triazolo[4,3-d][1,2,3,4]thiatriazole derivatives showed a broad spectrum of antitumor activity, with GI50 values lower than 13 μM for all cell lines tested. In general, all tested compounds showed potent activity against the breast (MCF-7) cancer cell line, with GI50 values in the range of 2.07 to 4.58 μM.

 
  • References

  • 1 Tonin LT. Panice MR. Nakamura CV. Rocha KJ. P. Dos Santos AO. Ueda-Nakamura T. Da Costa WF. Sarragiotto MH. Biomed. Pharmacother. 2010; 64: 386
  • 2 Valdez RH. Tonin LT. Ueda-Nakamura T. Silva SO. Dias Filho BP. Kaneshima EN. Yamada-Ogatta SF. Yamauchi LM. Sarragiotto MH. Nakamura CV. Antimicrob. Agents Chemother. 2012; 56: 507
  • 3 Gohil MV. Brahmbhatt KG. Loiseau PM. Bhutani KK. Bioorg. Med. Chem. Lett. 2012; 22: 3905
  • 4 Weng QF. Huang JF. Zeng Y. Deng YY. Hu MY. Molecules 2012; 17: 3969
  • 5 Song HJ. Liu YX. Liu YX. Wang LZ. Wang QM. J. Agric. Food Chem. 2014; 62: 1010
  • 6 Formagio AS. N. Santos PR. Zanoli K. Ueda-Nakamura T. Tonin LT. D. Nakamura CV. Sarragiotto MH. Eur. J. Med. Chem. 2009; 44: 4695
  • 7 Ashok P. Sharma H. Lathiya H. Chander S. Murugesan S. Med. Chem. Res. 2015; 24: 513
  • 8 Ashok P. Chander S. Ganguly S. Murugesan S. Med. Chem. Res. 2014; 23: 3662
  • 9 Liu JW. Jiang XY. Zhao M. Zhang XY. Zheng MQ. Peng L. Peng SQ. J. Med. Chem. 2010; 53: 3106
  • 10 Yao K. Zhao M. Zhang XY. Wang YJ. Li L. Zheng MQ. Peng SQ. Eur. J. Med. Chem. 2011; 46: 3237
  • 11 Polanski W. Reichmann H. Gille G. Expert Rev. Neurother. 2011; 11: 845
  • 12 Drung B. Scholz C. Barbosa VA. Nazari A. Sarragiotto MH. Schmidt B. Bioorg. Med. Chem. Lett. 2014; 24: 4854
  • 13 Adayev T. Wegiel J. Hwang Y. Arch. Biochem. Biophys. 2011; 507: 212
  • 14 Chen ZY. Cao RH. Yu LA. Shi BX. Sun J. Guo LA. Ma Q. Yi W. Song XA. Song HC. Eur. J. Med. Chem. 2010; 45: 4740
  • 15 Cao RH. Guan X. Shi BX. Chen Z. Ren ZH. Peng W. Song HC. Eur. J. Med. Chem. 2010; 45: 2503
  • 16 Zhang GX. Cao RH. Guo L. Ma Q. Fan WX. Chen XM. Li JR. Shao G. Qiu LQ. Ren ZH. Eur. J. Med. Chem. 2013; 65: 21
  • 17 Shi BX. Cao RH. Fan WX. Guo L. Ma Q. Chen XM. Zhang GX. Qiu LQ. Song HC. Eur. J. Med. Chem. 2013; 60: 10
  • 18 Chen H. Gao PC. Zhang M. Liao W. Zhang JW. New J. Chem. 2014; 38: 4155
  • 19 Wu QF. Bai ZS. Ma Q. Fan WX. Guo L. Zhang GX. Qiu LQ. Yu HJ. Shao G. Cao RH. MedChemComm 2014; 5: 953
  • 20 Ghasemi JB. Davoudian V. J. Chem. 2014; 2014: 1
  • 21 Lin Y. Xia XP. Yao RX. Ni L. Hu J. Guo WJ. Zhu BL. Chem. Pharm. Bull. 2014; 62: 343
  • 22 Kamal A. Srinivasulu V. Nayak VL. Sathish M. Shankaraiah N. Bagul C. Reddy NV. S. Rangaraj N. Nagesh N. ChemMedChem 2014; 9: 2084
  • 23 Kamal A. Sathish M. Nayak VL. Srinivasulu V. Kavitha B. Tangella Y. Thummuri D. Bagul C. Shankaraiah N. Nagesh N. Bioorg. Med. Chem. 2015; 23: 5511
  • 24 Formagio AS. N. Tonin LT. D. Foglio MA. Madjarof C. De Carvalho JE. Da Costa WF. Cardoso FP. Sarragiotto MH. Bioorg. Med. Chem. 2008; 16: 9660
  • 25 Savariz FC. Formagio AS. N. Barbosa VA. Foglio MA. De Carvalho JE. Duarte MC. T. Dias Filho BP. Sarragiotto MH. J. Braz. Chem. Soc. 2010; 21: 288
  • 26 Barbosa VA. Formagio AS. N. Savariz FC. Foglio MA. Spindola HM. De Carvalho JE. Meyer E. Sarragiotto MH. Bioorg. Med. Chem. 2011; 19: 6400
  • 27 Savariz FC. Foglio MA. Ruiz AL. Da Costa WF. Silva MM. Santos JC. Figueiredo IM. Meyer E. De Carvalho JE. Sarragiotto MH. Bioorg. Med. Chem. 2014; 22: 6867
  • 28 Kaplancıklı ZA. Turan-Zitouni G. Özdemir A. Revial G. Eur. J. Med. Chem. 2008; 43: 155
  • 29 Suresh Kumar GV. Rajendra Prasad Y. Mallikarjuna BP. Chandrashekar SM. Eur. J. Med. Chem. 2010; 45: 5120
  • 30 Chidananda N. Poojary B. Sumangala V. Kumari NS. Shetty P. Arulmoli T. Eur. J. Med. Chem. 2012; 51: 124
  • 31 El Shehry MF. Abu-Hashem AA. El-Telbani EM. Eur. J. Med. Chem. 2010; 45: 1906
  • 32 Ramaprasad GC. Balakrishna K. Sunil Kumar B. Med. Chem. Res. 2014; 23: 3644
  • 33 Monks A. Scudiero D. Skehan P. Shoemaker R. Paull K. Vistica D. Hose C. Langley J. Cronise P. Vaigro-Wolff A. Gray-Goodrich M. Campbell H. Mayo J. Boyd M. J. Natl. Cancer Inst. 1991; 83: 757